Sanofi's second medical use patent revoked by UPC in win for generics
French company Sanofi has lost its claim for a patent for a new therapeutic use for its established cancer drug to three generic pharmaceutical companies, Stada, Dr. Reddy’s and Zentiva. The ruling...To view the full article, register now.
Already a subscriber? Click here to view full article